Cargando…
Chondrosarcoma: A Clinical Review
Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing neoplasms. Conventional chondrosarcomas are a continuum of disease based on the biologic activity of the tumor. The tumors range from the relatively biologically benign low-grade tumors or intermediate atypical cartilagi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095313/ https://www.ncbi.nlm.nih.gov/pubmed/37048590 http://dx.doi.org/10.3390/jcm12072506 |
_version_ | 1785024054096297984 |
---|---|
author | Gazendam, Aaron Popovic, Snezana Parasu, Naveen Ghert, Michelle |
author_facet | Gazendam, Aaron Popovic, Snezana Parasu, Naveen Ghert, Michelle |
author_sort | Gazendam, Aaron |
collection | PubMed |
description | Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing neoplasms. Conventional chondrosarcomas are a continuum of disease based on the biologic activity of the tumor. The tumors range from the relatively biologically benign low-grade tumors or intermediate atypical cartilaginous tumors (ACTs), to malignant, aggressive high-grade tumors. The clinical presentation, radiographic and pathologic findings, treatments and outcomes vary significantly based on the histologic grade of the tumor. Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. A multidisciplinary team at a tertiary sarcoma centre allows for optimal care of these patients. |
format | Online Article Text |
id | pubmed-10095313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100953132023-04-13 Chondrosarcoma: A Clinical Review Gazendam, Aaron Popovic, Snezana Parasu, Naveen Ghert, Michelle J Clin Med Review Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing neoplasms. Conventional chondrosarcomas are a continuum of disease based on the biologic activity of the tumor. The tumors range from the relatively biologically benign low-grade tumors or intermediate atypical cartilaginous tumors (ACTs), to malignant, aggressive high-grade tumors. The clinical presentation, radiographic and pathologic findings, treatments and outcomes vary significantly based on the histologic grade of the tumor. Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. A multidisciplinary team at a tertiary sarcoma centre allows for optimal care of these patients. MDPI 2023-03-26 /pmc/articles/PMC10095313/ /pubmed/37048590 http://dx.doi.org/10.3390/jcm12072506 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gazendam, Aaron Popovic, Snezana Parasu, Naveen Ghert, Michelle Chondrosarcoma: A Clinical Review |
title | Chondrosarcoma: A Clinical Review |
title_full | Chondrosarcoma: A Clinical Review |
title_fullStr | Chondrosarcoma: A Clinical Review |
title_full_unstemmed | Chondrosarcoma: A Clinical Review |
title_short | Chondrosarcoma: A Clinical Review |
title_sort | chondrosarcoma: a clinical review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095313/ https://www.ncbi.nlm.nih.gov/pubmed/37048590 http://dx.doi.org/10.3390/jcm12072506 |
work_keys_str_mv | AT gazendamaaron chondrosarcomaaclinicalreview AT popovicsnezana chondrosarcomaaclinicalreview AT parasunaveen chondrosarcomaaclinicalreview AT ghertmichelle chondrosarcomaaclinicalreview |